Galya Blachman

CLO and Head of Business Development, Enliven Therapeutics

About

Female

Galya Blachman is the Chief Legal Officer and Head of Business Development at Enliven Therapeutics.She has completed a Ph.D. in Pharmacology from Cambridge University.

Experience

Enliven Therapeutics

CLO and Head of Business Development

View →

IPO67Boulder, Colorado, United StatesBiotech/Pharma · Biotechnology

Education

University of Cambridge · Ph.D., Pharmacology

Headlines from Google News. Social posts load from the platform only when you open a tab.

Former Genentech exec moves company to Bay Area from Colorado with $400 million in the bank
The Business Journals · Jun 17

People at Enliven Therapeutics

Anish Patel

Co-founder and Chief Operating Ofﬁcer

Joe Lyssikatos

Co-founder and Chief Scientiﬁc Ofﬁcer

Rick Fair

Chief Executive Officer

Sam Kintz

Head of Pipeline

Data from: crunchbase